Edit Game
Unit 8 drugs
 Delete

Use commas to add multiple tags

 Private  Unlisted  Public



 Save

Delimiter between question and answer:

Tips:

  • No column headers.
  • Each line maps to a question.
  • If the delimiter is used in a question, the question should be surrounded by double quotes: "My, question","My, answer"
  • The first answer in the multiple choice question must be the correct answer.






 Save   12  Close
What is the first-line treatment for anxiety disorders
g
Identify two subclasses of sedative-hypnotics to treat insomnia. Include MOA
f
Distinguish abortive and preventative pharmacotherapies for migraine headache.
h
Justify the use of diuretics in the treatment of Meniere's disease
Theoretically improves symptoms by reducing the endolymph volume but high-quality studies on the effect of diuretics are lacking
Justify the use of tPA in ischemic stroke
Alteplase
Outline how cannabinoids would alter action potentials to improve MS-related spasticity.
Cannabinoids decrease the release of pre-synaptic glutamate-> decrease the amplitude of EPSPs-> decrease excitability of motor pathway in CNS ->
What is the MOA of the second-line Alzheimer disease treatment
Memantine - NMDA receptor blocker - decreases effects of glutamate (known to cause neuronal toxicity)
What is the MOA of the first-line Alzheimer disease treatment
Donepezil - cholinesterase inhibitor - Boost the amount of ACh in the brain -> higher ACh in synapse, more likely to have a signal -> improve symptoms of dement
Identify a physiologic rationale for the declining efficacy of carbidopa-levodopa treatment over time in PD.
d
Identify the MOA of the six different drug therapies used to manage PD symptoms
COMT inhibitor (Tolcapone)) and MAO-B inhibitor (Selegiline) ->
Explain the rationale for the use of fosphenytoin for seizure prophylaxis following TBI
Anticonvulsant - stabilize neuronal membranes & decrease seizure activity by increase efflux/decrease influx Na+ across cell membrane during generation nerve im
Rationalize the use of mannitol in acute TBI
reduce ICP by reducing blood viscosity -> increases cerebral blood flow and oxygen transport and constricts pial arterioles -> reduce cerebral blood volume, ICP